Last updated: 2026-09-16 09:45:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Insulet Corporation (PODD) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $139,91, with a market capitalisation of $9,56B and a P/E ratio of 25,73. Over the past 52 weeks, its price has ranged from $126,40 to $354,88. This page covers its latest market performance, valuation, price trends and company information.
$9,56B | |
$139,23 | |
$354,88 | |
$2,57 | |
$139,24 | |
1,65K | |
1,67M | |
25,73 | |
$354,88 | |
$126,40 | |
-- | |
-- |
Insulet Corporation (PODD) is trading at $139,91 in pre-market trading as of 2026-09-16 09:18:00, up 0,48% ($0,66) from the previous close of $139,24
Pre-market trading shows how investors are pricing PODD before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.
Over the past seven days, Insulet Corporation (PODD) moved from $147,48 to $139,91, representing a decline of 5,14% ($7,57).
The stock traded between $131,24 and $150,56 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 1,83 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 5,9%
PODD is currently trading at $139,91, placing it 5,9% of the way from its 52-week low of $126,40 to its 52-week high of $354,88. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 5400 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Insulet Corporation (PODD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.